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Background: The impact of functional testing by myocardial perfusion SPECT (MPS) compared to anatomic testing by 64-detector row coronary 
computed tomographic angiography (CCTA) on outcomes is unknown.
Methods: We randomized intermediate-risk stable chest pain pts without known coronary artery disease at 2 sites to initial evaluation by CCTA 
versus MPS. Patients were evaluated for near-term medication use, functional status, resource utilization, and major adverse cardiac events (MACE).
Results: 181 pts were randomized (CCTA=92; MPS=89). Follow-up occurred at 54±31 days for 96% of subjects. Mean age was 58.1±10.4; 50.0% 
were men. No MACE occurred during follow-up. Baseline and 30-day follow-up is described in Table 1. No differences existed between groups for 
CAD hospitalization, invasive angiography, revascularization, or non-invasive testing. No differences existed for within-person changes in functional 
status as assessed by the Duke Activity Status Inventory [0.0071 vs -0.098 change in score, p = 0.44), or angina frequency [1.04 vs 0.88 category 
improvement, p = 0.44]. CCTA subjects were more likely than MPS subjects to initiate aspirin (26.3% vs 12.2%, p=0.03) and statins (18.1% vs. 
3.9%; p = 0.007), with no difference in other medications.
Conclusions: Near-term resource utilization, functional status and coronary revascularization are similar among patients undergoing MPS or CCTA. 
Compared to MPS, CCTA evaluation is associated with increased new use of aspirin and statins.
